# Study of LYM-X-SORB™ to Improve Fatty Acid and Choline Status in Children With CF and PI

> **NCT00406536** · PHASE2 · COMPLETED · sponsor: **Avanti Polar Lipids, Inc.** · enrollment: 110 (actual)

## Conditions studied

- Cystic Fibrosis
- Pancreatic Insufficiency

## Interventions

- **DIETARY_SUPPLEMENT:** Lym-X-Sorb powder
- **DIETARY_SUPPLEMENT:** Placebo powder

## Key facts

- **NCT ID:** NCT00406536
- **Lead sponsor:** Avanti Polar Lipids, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2013-01-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00406536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00406536, "Study of LYM-X-SORB™ to Improve Fatty Acid and Choline Status in Children With CF and PI". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT00406536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*